208 results on '"Nawa, Yuichiro"'
Search Results
2. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
3. Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics
4. Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia
5. Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study
6. Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia
7. Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group
8. A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia
9. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group
10. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
11. Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan
12. Hematopoietic Stem Cell Transplantation in Solid Organ Recipients with Emphasis on Transplant Complications: A Nationwide Retrospective Survey on Behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group
13. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
14. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
15. The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation
16. Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study.
17. The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation.
18. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan
19. Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
20. Prior administration of foscarnet may result in viremia-negative post-transplant human herpesvirus-6B encephalitis
21. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study
22. Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan
23. Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia
24. Health-related QOL challenges and coping ability of patients after treatment for acute leukemia: qualitative analysis
25. A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
26. Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission
27. Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group
28. Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma
29. The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis
30. Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
31. Prevalence of organ symptoms in allo-HCT survivors and their impact on work and daily life
32. Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome
33. Single-Dose Daily Infusion of Cyclosporine for Prevention of Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation from HLA Allele-Matched, Unrelated Donors
34. Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia
35. FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings
36. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma
37. Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood
38. Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase
39. Familial occurrence of chronic neutrophilic leukaemia
40. Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
41. Prognosis of patients with core binding factor acute myeloid leukemia after first relapse
42. An unusual, CD4 and CD8 dual-positive, CD25 negative, tumor cell phenotype in a patient with adult T-cell leukemia/lymphoma
43. Hyponatremia during Administration of Tacrolimus in an Allogeneic Bone Marrow Transplant Recipient
44. Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
45. Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707
46. CD79 Expression Is Associated with Cell-of-Origin and Outcome in Diffuse Large B-Cell Lymphoma
47. Qualitative Analysis of Patient-Reported Free Comments on Quality of Life in Patients Who Completed Treatment for Acute Leukemia
48. A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
49. Action mechanisms of complex spa therapy on bronchial asthma. 3. Relationship to airway inflammation
50. Type Ⅱ (bronchiolar obstruction) asthma and number of neutrophils in bronchoalveolar lavage (BAL) fluid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.